Physician profile
Peter I Tsai
NPI 1265684583
$51,258.27
in general payments reported to CMS, 2019-2025
34 companies · $4,784 in 2025
The $4,784 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $784 · 2021: $4,489 · 2022: $12K · 2023: $9,635 · 2024: $7,358 · 2025: $4,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Travel and Lodging: $4,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,294.09 |
| Travel and Lodging | $4,482.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $9,699.06 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $8,805.84 | 2019-2025 | Impella |
| Kls-Martin L.P. | $5,014.24 | 2021-2025 | |
| Artivion, INC. | $4,710.65 | 2019-2025 | Cryovalve Sg Pulmonary Human Heart Valve, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Medtronic, INC. | $4,570.22 | 2021-2025 | Avalus, Penditure, Mosaic |
| Abbott Laboratories | $4,240.50 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Navitor |
| Medtronic Vascular, INC. | $2,718.78 | 2019-2020 | |
| Edwards Lifesciences Corporation | $2,076.50 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Corcym INC | $1,897.06 | 2022-2025 | Perceval |
| Ethicon US, LLC | $827.80 | 2019-2025 | Prolene, Vistaseal, Ethicon |
| Angiodynamics, INC. | $818.16 | 2022-2024 | Angiovac |
| Bolton Medical INC | $607.92 | 2024-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Smith+Nephew, INC. | $574.98 | 2020-2025 | Grafix Pl, Stravix, Grafix |
| W. L. Gore & Associates, INC. | $555.76 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| E.R. Squibb & Sons, L.L.C. | $536.36 | 2019-2025 | Camzyos, Eliquis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $460.71 | 2024 | Carto 3 |
| Livanova USA, INC. | $403.05 | 2019-2023 | Protekduo |
| Zimmer Biomet Holdings, INC. | $323.56 | 2019-2022 | |
| Biom'Up Sa | $292.34 | 2019 | |
| Lsi Solutions INC | $255.85 | 2019-2020 | |
| Boston Scientific Corporation | $224.99 | 2019-2021 | |
| Philips North America LLC | $204.20 | 2019-2021 | |
| Biom'Up France Sas | $198.48 | 2021 | |
| Dilon Technologies, INC. | $178.56 | 2023 | Hemoblast Bellows |
| Depuy Synthes Sales INC. | $173.65 | 2025 | Matrixrib, Na |
| Heartflow, INC. | $165.90 | 2024 | |
| Elevate Surgical Co | $147.58 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.33 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $119.38 | 2025 | |
| Davol INC. | $76.20 | 2020 | |
| Amgen INC. | $51.85 | 2025 | Repatha |
| Lemaitre Vascular, INC. | $37.51 | 2025 | Restoreflow |
| Bayer Healthcare Pharmaceuticals INC. | $26.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.